APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 34 filers reported holding APPLIED DNA SCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,000 | -60.0% | 20,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $10,000 | -28.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $14,000 | +75.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -73.3% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $30,000 | +20.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $25,000 | -13.8% | 20,000 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $29,000 | -9.4% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $32,000 | -43.9% | 20,000 | 0.0% | 0.00% | -66.7% |
Q3 2017 | $57,000 | +62.9% | 20,000 | 0.0% | 0.01% | +100.0% |
Q2 2017 | $35,000 | +6.1% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $33,000 | -10.8% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $37,000 | -38.3% | 20,000 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $60,000 | -7.7% | 20,000 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $65,000 | -5.8% | 20,000 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $69,000 | +6.2% | 20,000 | 0.0% | 0.01% | +20.0% |
Q4 2015 | $65,000 | -14.5% | 20,000 | 0.0% | 0.01% | -28.6% |
Q3 2015 | $76,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
Creative Planning | 56,234 | $172,000 | 0.00% |